Objective: The ATP-binding cassette transporter A1 (ABCA1) R230C variant is associated with low high density lipoprotein-cholesterol (HDL-C) levels, obesity and the metabolic syndrome in Mexican-Mestizos. Because a pivotal role for ABCA1 in pancreatic beta-cell function was recently observed in the mouse model, we assessed the association of this variant with type 2 diabetes in this population.
Results: R230C/C230C genotypes were significantly more frequent in type 2 diabetic individuals (24.6%) than in controls (11.4%) in the initial study group (OR = 2.501; P=0.001). After stratifying by age at diagnosis, the association was significant only in the early-onset group (age at diagnosis ≤ 45 years) (OR=3.776; P=3.3 x 10 -6 ). Both associations remained significant after adjusting for admixture (P=0.0008 and P=8.1 x 10 -6 , respectively). Similar trends were observed in the independent study group, and the combined analysis of both populations showed a highly significant association of the R230C variant with type 2 diabetes, particularly with that of earlyonset (P=7.6 x 10 -6 and 9.4 x 10 -8 , respectively).
Conclusion:
The R230C ABCA1 variant is associated with type 2 diabetes, particularly of early-onset in the Mexican-Mestizo population.
ABBREVIATIONS. ABCA1, ATP-binding cassette transporter A1; Apo A-I, apolipoprotein A-I; HDL-C, high density lipoprotein-cholesterol; SNPs, single nucleotide polymorphisms; AIMs, ancestry informative markers; BMI, body mass index; HbA1c, hemoglobin A1c.
he identification of ATP-binding cassette transporter A1 (ABCA1) as the defective gene in Tangier disease has contributed substantially to the understanding of its role as a key transporter of cholesterol and phospholipids across cell membranes to acceptor molecules such as apolipoprotein (Apo) A-I (1-3). While the role of ABCA1 in high density lipoprotein (HDL) formation is well known, it may have multiple and diverse functions in other tissues (4, 5) . ABCA1 is expressed in pancreatic beta-cells and is regulated by a transcriptional regulatory network including several proteins and drugs involved in lipid and glucose metabolism (6, 7) . Moreover, insulin downregulates ABCA1 expression in vitro, while glucose upregulates ABCA1 expression in leukocytes in vivo (8, 9) . Very recently, mice with specific inactivation of ABCA1 in beta-cells showed accumulation of cellular cholesterol, marked insulin secretion reduction in vivo and progressive glucose tolerance impairment, establishing a pivotal role for ABCA1 in pancreatic beta-cell function (10) .
Although there is solid evidence of the role of ABCA1 in glucose metabolism, the association of ABCA1 with type 2 diabetes in humans has not been thoroughly studied. Daimon et al. (11) reported an ABCA1 diplotype associated with type 2 diabetes in the Japanese population, suggesting this gene may have influence on the pathophysiology of type 2 diabetes independently of serum high density lipoprotein-cholesterol (HDL-C) levels. In a previous study, we found an apparently functional ABCA1 variant significantly associated not only with low HDL-C levels, but also with obesity and the metabolic syndrome, that is apparently exclusive to Amerindian and Amerindian-derived populations such as Mexican-Mestizos. We also observed an association of this variant with type 2 diabetes in a reduced number of diabetic individuals recruited from general population (12) . Based on this evidence, we sought to confirm and further investigate the role of the ABCA1 R230C variant in type 2 diabetes in this population.
RESEARCH DESIGN AND METHODS

Subjects.
The initial study group included 244 unrelated Mexican-Mestizo diabetic patients attending three different reference centers in Mexico City, diagnosed between ages 20-80 years. Type 2 diabetes was diagnosed according to World Health Organization criteria (13) . To reduce the probability of including control individuals who may develop type 2 diabetes in later life, a group of 202 unrelated non-diabetic subjects with no family history of diabetes aged 50 to 80 years comprised the control group: 68 controls from a previous study (12) , and 134 additional controls who met the same criteria. Absence of diabetes was defined as no medical history of diabetes and fasting glucose levels ≤ 5.5 mmol/l. Only individuals born in Mexico whose parents and grandparents identified themselves as Mexican-Mestizos were included.
The association test was replicated in an independent group of type 2 diabetes patients (n=242) and controls (n=225, aged 45 to 65 years) recruited from the 'Siglo XXI' Medical Center of the Mexican Institute of Social Security (IMSS) in Mexico City, as described previously (14 
, and haplotypes were inferred for each individual using Haploview (version 3.2) (16). Table 1 compares anthropometric and biochemical measurements in diabetic and control individuals of the initial study group. Significantly lower fasting insulin and higher hemoglobin (Hb) A1c levels were observed in R230C/C230C than in R230R diabetic subjects (P=0.011 and 0.015, respectively; adjusted by age, sex, BMI, duration of diabetes, and treatment), however differences in insulin levels according to genotype were not observed in non-diabetic subjects.
RESULTS
Overall, R230C/C230C genotypes were significantly more frequent in type 2 diabetes individuals (24.6%) than in controls (11.4%; OR=2.501; 95% CI, 1.476-4.238; P=0.001) ( Table 2) , even after adjusting for admixture (P=0.0008).
Interestingly, age at diagnosis was significantly lower in R230C/C230C than in R230R diabetic individuals (42.6 ± 9.3 years vs. 47.0 ± 10.9 years, respectively; P=0.005, adjusted by sex and BMI) ( Table 1) . We then tested the association of R230C with early-onset type 2 diabetes (<45 years, n=121), based on the average age of diagnosis of R230C/C230C individuals and on the previous use of 45 years as cutoff age in linkage and association studies for type 2 diabetes (17, 18) . While the association of R230C/C230C with late-onset type 2 diabetes (>45 years, n=123) was not significant (P=0.149), its association with early-onset type 2 diabetes was highly significant (OR=3.776; 95% CI, 2.121-6.748; P=3.3 x 10 -6 ) even after adjusting for admixture (8.1 x 10 -6 ) ( Table 2 ). Figure 1 shows the approximate genomic locations of the 4 additional SNPs tested and linkage disequilibrium (LD) estimates in the initial study group. There was no evidence for LD between R230C and the other 4 SNPs. Individually, all SNPs other than R230C failed to show association with type 2 diabetes (P>0.311, (12), we tested the association including only obese individuals. R230C/C230C genotypes were significantly more frequent in obese diabetic than in obese nondiabetic individuals (P=0.001).
DISCUSSION
The ABCA1 R230C variant was significantly associated with type 2 diabetes in the Mexican population. Because the association remained significant after adjusting for admixture, it is unlikely that population stratification confounded our analysis. Moreover, R230C was not in linkage disequilibrium with any other SNP tested in neighboring haplotype blocks within the ABCA1 gene, suggesting that the R230C variant is functional and is a significant risk allele for type 2 diabetes in Mexican population. Interestingly, the association with type 2 diabetes was highly significant in the early-onset group. This is epidemiologically relevant in the Mexican population because type 2 diabetes is highly prevalent (8.2%) (19) , approximately 15% are diagnosed before age 40 years (20) , and earlyonset leads to longer exposure to risk factors related to complications of diabetes (21) .
It is important to point out this study was conducted based on a previous observation in a reduced group of diabetic individuals who showed a very high frequeçncy of R230C/C230C genotypes (41.2%) (12) . These individuals were recruited from the general population, and most were unaware of their condition when interviewed. In contrast, the 486 diabetic individuals analyzed here were attending specialized clinics, and were significantly older than the previously published group of diabetic individuals (mean age 54.0 ± 11.7 vs. 49.6 ± 11.8 years; P=0.03). This age difference or other population stratification factors may explain the higher R230C/C230C genotype frequency reported in first group.
Obesity is known to lead to insulin resistance, implicated as one of the main determinants of type 2 diabetes (22) . Because R230C was previously found to be associated with obesity and obesity-related comorbidities (12) , it could be speculated that it confers susceptibility to type 2 diabetes through obesity and insulin resistance. However, 10 to 40% of diabetic individuals are not insulin resistant (23) . Aguilar-Salinas et al. (24) reported a high frequency of insulin secretion deficiency (85%) coexisting with insulin resistance in 35% of the cases, in a group of early-onset type 2 diabetes Mexican individuals. Even though the mechanisms by which ABCA1 deficiency could lead to type 2 diabetes in humans have not been studied, Brunham et al. (10) recently reported that cholesterol accumulation in the pancreatic beta-cell leads to insulin secretion failure in the mouse model, which may be an important component of lipotoxicity in pancreatic islets. They also found that selective loss of ABCA1 in pancreatic beta-cells leads to agerelated progressive impairment in glucose tolerance even in heterozygous mice. Moreover, Hao et al. (25) found that excess cholesterol inhibits insulin secretion, opening a novel set of mechanisms that may contribute to beta-cell dysfunction and the onset of diabetes in obese patients. Detailed in vivo studies of the beta-cell function are required to assess the effect of this variant on beta-cell function.
In addition to its effect on insulin secretion, R230C may also be associated with type 2 diabetes through an increased risk of obesity. However, the R230C/C230C variants were significantly more frequent in obese diabetic than in obese non-diabetic individuals, suggesting that both associations may be independent. Thus, the consequences of this probably functional variant on pancreatic beta-cell and adipocyte function could lead to increased risk of type 2 diabetes by more than one mechanism which remain to be elucidated.
In conclusion, our findings suggest there is an association of the R230C variant with early-onset type 2 diabetes in Mexican-Mestizos, which is in accordance with recent findings on beta-cell physiology and the effects of cholesterol lipotoxicity on insulin secretion. This variant is epidemiologically relevant because of its high frequency and its association with type 2 diabetes. Functional analyses are required to further elucidate the role of ABCA1 variation in the pathogenesis of type 2 diabetes.
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